{"id":7399,"date":"2023-09-26T16:05:29","date_gmt":"2023-09-26T20:05:29","guid":{"rendered":"https:\/\/eczemahelp.ca\/?page_id=7399"},"modified":"2026-03-05T10:11:58","modified_gmt":"2026-03-05T15:11:58","slug":"references-medicales","status":"publish","type":"page","link":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/","title":{"rendered":"R\u00e9f\u00e9rences m\u00e9dicales"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Acc\u00e8s aux traitements<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Acc\u00e8s aux traitements<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

1. Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermat Contact Atopic Occup Drug. 2007;18(2):82-91.<\/p>\n

2. Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate Atopic Dermatitis. JAMA Dermatol. 2014;150(6):593-600. doi:10.1001\/jamadermatol.2013.10271. <\/span><\/p>\n

3. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132(5):1132-1138. doi:10.1016\/j.jaci.2013.08.031. <\/span><\/p>\n

4. Saavedra JM, Boguniewicz M, Chamlin S, et al. Patterns of Clinical Management of Atopic Dermatitis in Infants and Toddlers: A Survey of Three Physician Specialties in the United States. JPediatr.2013;163(6):1747-1753.doi:10.1016\/j.jpeds.2013.06.073. <\/span><\/p>\n

5. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis \u2014 Section 2. J Am Acad Dermatol.2014;71(1):116-132. doi:10.1016\/j.jaad.2014.03.023. <\/span><\/p>\n

6. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis \u2014 Section 1. J Am Acad Dermatol.2014;70(2):338-351. doi:10.1016\/j.jaad.2013.10.010. <\/span><\/p>\n

7. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis \u2014 Section 3. J Am Acad Dermatol. 2014;71(2):327-349.doi:10.1016\/j.jaad.2014.03.030.<\/p>\n

8. Sidbury R, Tom WL, Bergman JN, et al. Guidelines of Care for the Management of Atopic Dermatitis Part 4: Prevention of Disease Flares and Use of Adjunctive Therapies and Approaches. J Am Acad Dermatol.2014;71(6):1218-1233. doi:10.1016\/j.jaad.2014.08.038. <\/span><\/p>\n

9. Stern RS, Nelson C. The diminishing role of the dermatologist in the office-based care of cutaneous diseases. J Am Acad Dermatol.1993;29(5 Pt 1):773-777. <\/span><\/p>\n

10. Hanifin JM. Diagnostic features of atopic dermatitis. Acta Derm Venereol.1980;92:44-47<\/p>\n

11. Su J, Kemp A, Varigos G, Nolan T. Atopic eczema: its impact on the family and financial cost. Arch Dis Child. 1997;76(2):159-162. <\/span><\/p>\n

12. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009;9(5):437-446. doi:10.1097\/ACI.0b013e32832e7d36.<\/p>\n

13. Lindh JD, Bradley M. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review. Am J Clin Dermatol.2015;16(5):341-359. doi:10.1007\/s40257-015-0146-4. <\/span><\/p>\n

14. Lynde CW. Moisturizers: what they are and how they work. Skin Ther Lett.2001;6(13):3-5. <\/span><\/p>\n

15. Chiang C, Eichenfield LF. Quantitative assessment of combination bathing and\/or moisturizing regimens on skin hydration in atopic dermatitis.Pediatr Dermatol. 2009;26(3):273-278. doi:10.1111\/j.1525-1470.2009.00911.x<\/p>\n

16. Simpson E, Trookman NS, Rizer RL, et al. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study. Pediatr Dermatol. 2012;29(5):590-597. doi:10.1111\/j.1525-1470.2012.01809.x<\/p>\n

17. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess Winch Engl. 2000;4(37):1-191. <\/span><\/p>\n

18. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138(2):293-296. <\/span><\/p>\n

19. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164(2):415-428.doi:10.1111\/j.1365-2133.2010.10030.x <\/span><\/p>\n

20. Hong E, Smith S, Fischer G. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients. Pediatr Dermatol.2011;28(4):393-396. doi:10.1111\/j.1525-1470.2011.01445.x <\/span><\/p>\n

21. Hajar T, Leshem YA, Hanifin JM, et al. A systematic review of topical corticosteroid withdrawal (\u201csteroid addiction\u201d) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541-549.e2. doi:10.1016\/j.jaad.2014.11.024. <\/span><\/p>\n

22. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156(2):203-221.doi:10.1111\/j.1365-2133.2006.07538.x<\/p>\n

23. Ntuen E, Taylor SL, Kinney M, O\u2019Neill JL, Krowchuk DP, Feldman SR. Physicians\u2019 perceptions of an eczema action plan for atopic dermatitis. J Dermatol Treat. 2010;21(1):28-33. doi:10.3109\/09546630903386598. <\/span><\/p>\n

24. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ.2005;330(7490):516. doi:10.1136\/bmj.38376.439653.D3. <\/span><\/p>\n

25. Tha\u00e7i D, Reitamo S, Gonzalez Ensenat MA, et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol. 2008;159(6):1348-1356. doi:10.1111\/j.1365-2133.2008.08813.x <\/span><\/p>\n

26. Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy.2008;63(7):742-750. <\/span><\/p>\n

27. Leo Pharma Inc. Protopic Product Monograph. Thornhill, Ontario:Leo Pharma Inc.; 2016. <\/span><\/p>\n

28. Valeant Canada. Elidel \u2014 Product Monograph. Laval, Quebec:Valeant Canada; 2014. <\/span><\/p>\n

29. Tennis P, Gelfand JM, Rothman KJ. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol.2011;165(3):465-473. doi:10.1111\/j.1365-2133.2011.10363.x <\/span><\/p>\n

30. Ring J, M\u00f6hrenschlager M, Henkel V. The US FDA \u201cblack box\u201d warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf.2008;31(3):185-198. <\/span><\/p>\n

31. Canadian Dermatology Association. Topical Calcineurin Inhibitors Position Statement. Canadian Dermatology Association. https:\/\/dermatology.ca\/tci-position-statement\/. Published May 2018. Accessed September 6, 2018. <\/span><\/p>\n

32. Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494-503.e6. doi:10.1016\/j.jaad.2016.05.046. <\/span><\/p>\n

33. Zane LT, Chanda S, Jarnagin K, Nelson DB, Spelman L, Gold LS. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Immunotherapy. 2016;8(8):853-866.doi:10.2217\/imt-2016-0023. <\/span><\/p>\n

34. Pfizer Canada. Eucrisa \u2014 Product Monograph. Kirkland, Quebec:Pfizer Canada; 2018. <\/span><\/p>\n

35. Jarnagin K, Chanda S, Coronado D, et al. Crisaborole Topical Ointment, 2%:A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis. J Drugs Dermatol JDD. 2016;15(4):390-396. <\/span><\/p>\n

36. 36. Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed. 2007;23(4):106-112. doi:10.1111\/j.1600-0781.2007.00291.x <\/span><\/p>\n

37. Wollenberg A, Oranje A, Deleuran M, et al. ETFAD\/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30(5):729-747.doi:10.1111\/jdv.13599. <\/span><\/p>\n

38. Gooderham M, Lynde CW, Papp K, et al. Review of Systemic Treatment Options for Adult Atopic Dermatitis. J Cutan Med Surg.2016:1203475416670364. <\/span><\/p>\n

39. Shah N, Alhusayen R, Walsh S, Shear NH. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study. J Cutan Med Surg. June 2018:120347541878133.doi:10.1177\/1203475418781336. <\/span><\/p>\n

40. Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet Lond Engl.2017;389(10086):2287-2303. doi:10.1016\/S0140-6736(17)31191-1. <\/span><\/p>\n

41. Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768-775.doi:10.1111\/bjd.15928. <\/span><\/p>\n

42. Balma-Mena A, Lara-Corrales I, Zeller J, et al. Colonization with communityacquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int J Dermatol. 2011;50(6):682-688.doi:10.1111\/j.1365-4632.2010.04751.x <\/span><\/p>\n

43. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol. 2010;163(1):12-26. doi:10.1111\/j.1365-2133.2010.09743.x <\/span><\/p>\n

44. Hon KL, Tsang YCK, Lee VWY, et al. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial. J Dermatol Treat. 2016;27(2):156-162. doi:10.3109\/09546634.2015.1067669. <\/span><\/p>\n

45. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808-814.doi:10.1542\/peds.2008-2217. <\/span><\/p>\n

46. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-824. doi:10.1542\/peds.2007-2232. <\/span><\/p>\n

47. Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed Acyclovir and Outcomes of Children Hospitalized With Eczema Herpeticum. Pediatrics.2011;128(6):1161-1167. doi:10.1542\/peds.2011-0948. <\/span><\/p>\n

48. Boyce JA, Assa\u2019ad A, Burks AW, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. Nutr Res N Y N. 2011;31(1):61-75.doi:10.1016\/j.nutres.2011.01.001. <\/span><\/p>\n

49. Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev.2014;(1):CD004054. doi:10.1002\/14651858.CD004054.pub3. <\/span><\/p>\n

50. Barbarot S, Stalder JF. Therapeutic patient education in atopic eczema. Br J Dermatol. 2014;170 Suppl 1:44-48. doi:10.1111\/bjd.12932. <\/span><\/p>\n

51. Breuer K, Matterne U, Diepgen TL, et al. Predictors of benefit from an atopic dermatitis education programme. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2014;25(5):489-495.doi:10.1111\/pai.12249. <\/span><\/p>\n

52. Stalder J-F, Bernier C, Ball A, et al. Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol. 2013;30(3):329-334.doi:10.1111\/pde.12024. <\/span><\/p>\n

53. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931-936. <\/span><\/p>\n

54. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008;59(4):677-683. doi:10.1016\/j.jaad.2008.04.025.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Eczema-Society-of-Canada\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ressources sur l\u2019ecz\u00e9ma<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Trouvez des ressources pour aider \u00e0 am\u00e9liorer votre qualit\u00e9 de vie.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tExplorer les ressources sur l\u2019ecz\u00e9ma<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Abonnez-vous aux courriels<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Restez inform\u00e9s sur la prise en charge de l\u2019ecz\u00e9ma, les \u00e9v\u00e9nements gratuits, les mises \u00e0 jour de la recherche et les nouvelles de la collectivit\u00e9.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tS\u2019abonner maintenant<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Produits accept\u00e9s<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Consultez la liste des produits dignes de notre
Sceau d\u2019acceptation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tVoir tous les produits<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Acc\u00e8s aux traitements Acc\u00e8s aux traitements 1. Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermat Contact Atopic Occup Drug. 2007;18(2):82-91. 2. Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate Atopic Dermatitis. JAMA Dermatol. 2014;150(6):593-600. doi:10.1001\/jamadermatol.2013.10271. […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":3616,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-7399","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nAcc\u00e8s aux traitements | SCE<\/title>\n<meta name=\"description\" content=\"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acc\u00e8s aux traitements | SCE\" \/>\n<meta property=\"og:description\" content=\"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/\" \/>\n<meta property=\"og:site_name\" content=\"Eczema Society of Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EczemaSocietyofCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T15:11:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/references-medicales\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/references-medicales\\\/\",\"name\":\"Acc\u00e8s aux traitements | SCE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\"},\"datePublished\":\"2023-09-26T20:05:29+00:00\",\"dateModified\":\"2026-03-05T15:11:58+00:00\",\"description\":\"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/references-medicales\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/references-medicales\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/references-medicales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S\u2019impliquer\",\"item\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/simpliquer\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"R\u00e9f\u00e9rences m\u00e9dicales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"name\":\"Eczema Society of Canada\",\"description\":\"Educational Resources\",\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eczemahelp.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\",\"name\":\"Eczema Society of Canada\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":362,\"height\":360,\"caption\":\"Eczema Society of Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EczemaSocietyofCanada\",\"https:\\\/\\\/x.com\\\/EczemaSocietyCA\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/EczemaHelp\",\"https:\\\/\\\/www.instagram.com\\\/eczemasocietyofcanada\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acc\u00e8s aux traitements | SCE","description":"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/","og_locale":"fr_FR","og_type":"article","og_title":"Acc\u00e8s aux traitements | SCE","og_description":"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.","og_url":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/","og_site_name":"Eczema Society of Canada","article_publisher":"https:\/\/www.facebook.com\/EczemaSocietyofCanada","article_modified_time":"2026-03-05T15:11:58+00:00","twitter_card":"summary_large_image","twitter_site":"@EczemaSocietyCA","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/","url":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/","name":"Acc\u00e8s aux traitements | SCE","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/#website"},"datePublished":"2023-09-26T20:05:29+00:00","dateModified":"2026-03-05T15:11:58+00:00","description":"Voyez comment acc\u00e9der aux options de traitement offertes sur le march\u00e9 canadien.","breadcrumb":{"@id":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/references-medicales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eczemahelp.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"S\u2019impliquer","item":"https:\/\/eczemahelp.ca\/fr\/simpliquer\/"},{"@type":"ListItem","position":3,"name":"R\u00e9f\u00e9rences m\u00e9dicales"}]},{"@type":"WebSite","@id":"https:\/\/eczemahelp.ca\/#website","url":"https:\/\/eczemahelp.ca\/","name":"Eczema Society of Canada","description":"Educational Resources","publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eczemahelp.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/eczemahelp.ca\/#organization","name":"Eczema Society of Canada","url":"https:\/\/eczemahelp.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/","url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","width":362,"height":360,"caption":"Eczema Society of Canada"},"image":{"@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EczemaSocietyofCanada","https:\/\/x.com\/EczemaSocietyCA","https:\/\/www.youtube.com\/user\/EczemaHelp","https:\/\/www.instagram.com\/eczemasocietyofcanada\/"]}]}},"_links":{"self":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/pages\/7399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/comments?post=7399"}],"version-history":[{"count":4,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/pages\/7399\/revisions"}],"predecessor-version":[{"id":19301,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/pages\/7399\/revisions\/19301"}],"up":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/pages\/3616"}],"wp:attachment":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/media?parent=7399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}